Latest Press Releases
View all
TimeHeadline
17m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
18m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
18m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
18m agoFirst Quantum Minerals Reports First Quarter 2026 Results
18m agoDistrict Metals Announces $10 Million Private Placement Financing
Unicycive Therapeutics Inc logo

Unicycive Therapeutics Inc

About

Unicycive Therapeutics Inc (NASDAQ:UNCY) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 9 2026
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 30 2026
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Feb 4 2026
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
Jan 29 2026
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Jan 29 2026
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission

Financials

Revenue
$0
Market Cap
$174.9 M
EPS
-1.67

Community Chat

Ask AI

6ix6ixAIEvents